Respiratory Immunity and the Rationale for Immunomodulation in the Prevention of Respiratory Tract Infections

A narrative summary of selected presentations given  at the second Encuentro Latinoamericano de Infecciones  Respiratorias Recurrentes (ELAIR), an educational summit  held in Buenos Aires, Argentina, 4th–5th July 2015

Alberto Ciceran,1 Renato T. Stein2

1. University of Buenos Aires, Buenos Aires, Argentina
2. Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil

Disclosure: Each author received an honorarium from OM/Vifor Pharma (Meyrin, Switzerland) as regional experts and presenters at the ELAIR summit, Buenos Aires, Argentina.
Acknowledgements: Writing assistance was provided by Dr Ewen Legg of Halcyon Medical Writing.
Support: The publication of this article was funded by OM/Vifor Pharma. The views and opinions expressed are those of the authors and not necessarily those of OM/Vifor Pharma.
Citation: EMJ Respir. 2016;4(Suppl 1):27-33.


This educational summit, supported by an independent grant from OM/Vifor Pharma, brought together physicians specialising in pulmonary medicine, otolaryngology, surgery, immunology, and paediatrics. Delegates from the USA, Europe, and Latin America met and discussed the current unmet needs of patients suffering respiratory tract infections (RTIs). The meeting included plenary lectures, workshops,  and interactive sessions, allowing delegates and presenters to debate the most pressing local and  international issues in the field.

Download (PDF, 116KB)


Comments are closed.